CHANGES IN SERUM-LIPOPROTEINS DURING MALARIA THERAPY WITH PLASMODIUM-VIVAX

被引：10
|
作者：
MAUROIS, P
VERNES, A
CHARET, P
NOUVELOT, A
BECQUET, R
GIARD, R
机构：
[1] INST PASTEUR,PHYSIOPATHOL LIPIDES LAB,F-59000 LILLE,FRANCE
[2] CTR HOSP ST PHILIBERT,HOP CHARITE,LILLE,FRANCE
来源：
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY | 1979年 / 73卷 / 05期
关键词：
D O I：
10.1080/00034983.1979.11687289
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：491 / 493
页数：3
相关论文
共 50 条
  • [31] BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA CAUSED BY PLASMODIUM-VIVAX MALARIA
    YALE, SH
    ADLAKHA, A
    SEBO, TJ
    RYU, JH
    CHEST, 1993, 104 (04) : 1294 - 1296
  • [32] A CLINICAL-TRIAL OF MEFLOQUINE IN THE TREATMENT OF PLASMODIUM-VIVAX MALARIA
    DIXON, KE
    PITAKTONG, U
    PHINTUYOTHIN, P
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1985, 34 (03): : 435 - 437
  • [33] DETECTION OF ANTIGENS IN THE URINE OF PATIENTS WITH ACUTE PLASMODIUM-VIVAX MALARIA
    MILITAO, DNA
    CAMARGO, LMA
    KATZIN, AM
    EXPERIMENTAL PARASITOLOGY, 1993, 76 (02) : 115 - 120
  • [34] ANTIBODY-RESPONSE TO PLASMODIUM-VIVAX ANTIGENS IN HUMAN MALARIA
    SANCHEZ, MR
    RAMIREZ, JA
    RODRIGUEZ, MH
    OREILLY, F
    LARRALDE, C
    ORTIZORTIZ, L
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 50 (03): : 329 - 338
  • [35] CIRCUMSPOROZOITE PROTEIN HETEROGENEITY IN THE HUMAN MALARIA PARASITE PLASMODIUM-VIVAX
    ROSENBERG, R
    WIRTZ, RA
    LANAR, DE
    SATTABONGKOT, J
    HALL, T
    WATERS, AP
    PRASITTISUK, C
    SCIENCE, 1989, 245 (4921) : 973 - 976
  • [36] THE CHESSON STRAIN OF PLASMODIUM-VIVAX MALARIA .4. IMMUNITY
    WHORTON, CM
    PULLMAN, TN
    KIRSCHBAUM, WR
    JONES, R
    ALVING, AS
    CRAIGE, B
    EICHELBERGER, L
    COULSTON, F
    JOURNAL OF INFECTIOUS DISEASES, 1947, 81 (01): : 1 - 6
  • [37] CIRCUMSPOROZOITE PROTEINS OF HUMAN MALARIA PARASITES PLASMODIUM-FALCIPARUM AND PLASMODIUM-VIVAX
    NARDIN, EH
    NUSSENZWEIG, V
    NUSSENZWEIG, RS
    COLLINS, WE
    HARINASUTA, KT
    TAPCHAISRI, P
    CHOMCHARN, Y
    JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (01): : 20 - 30
  • [38] COMPOSITIONAL CHANGES IN SERUM-LIPOPROTEINS DURING SIMVASTATIN THERAPY IN TYPE-II HYPERLIPOPROTEINEMIA
    KAESER, P
    BIDLINGMEIER, M
    RUIZ, MJ
    BURNIER, M
    RIESEN, W
    DARIOLI, R
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (06): : 848 - 858
  • [39] CHANGES IN SERUM-LIPOPROTEINS AND HIGH-DENSITY-LIPOPROTEIN COMPOSITION DURING ISOTRETINOIN THERAPY
    OLEARY, TJ
    SIMO, IE
    KANIGSBERG, N
    WALKER, J
    GOODALL, JC
    OOI, TC
    CLINICAL AND INVESTIGATIVE MEDICINE, 1987, 10 (04): : 355 - 360
  • [40] EVOLUTION OF THE LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTORS DURING PLASMODIUM-FALCIPARUM AND PLASMODIUM-VIVAX MALARIA
    DELORON, P
    LEPERS, JP
    COULANGES, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (08) : 1887 - 1889
12345